| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/05/1998 | CA2259151A1 Enzyme and dna sequence encoding same |
| 03/04/1998 | EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase |
| 03/04/1998 | EP0826687A1 Carbapenem derivatives and antimicrobial agents comprising the same |
| 03/04/1998 | EP0826657A1 Compounds for modulation of hormone receptors, compositions containing them and their use in therapy |
| 03/04/1998 | EP0826374A2 Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
| 03/04/1998 | EP0826303A1 A method of preventing animals from diseases and improving immune function of animals |
| 03/04/1998 | EP0826062A1 Hbv vectors and cells for producing the same |
| 03/04/1998 | EP0826052A1 High molecular weight major outer membrane protein of moraxella |
| 03/04/1998 | EP0826043A1 Methods for modulating t cell survival by modulating bcl-x l? protein level |
| 03/04/1998 | EP0826001A1 Acellular pertussis vaccines and methods of preparation thereof |
| 03/04/1998 | EP0826000A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses |
| 03/04/1998 | EP0825995A1 Antibiotics |
| 03/04/1998 | EP0825993A1 Xanthines and their therapeutic use |
| 03/04/1998 | EP0825983A1 Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives |
| 03/04/1998 | EP0825875A1 Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence |
| 03/04/1998 | EP0825869A1 Pharmaceutical composition comprising lactobacillus plantarum and arginine |
| 03/04/1998 | EP0825860A1 Composition comprising amoxycillin and clavulanic acid |
| 03/04/1998 | EP0554389B1 Molecular clones of hiv-1 and uses thereof |
| 03/04/1998 | EP0542949B1 Hepatitis a virus strain, method for the isolation of said virus strains and hepatitis a vaccines |
| 03/04/1998 | CN1175260A Induction of cytotoxic t -lymphocyte responses |
| 03/04/1998 | CN1175258A Thienoxazinone derivatives useful as antiviral agents |
| 03/04/1998 | CN1175251A Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate thereof |
| 03/04/1998 | CN1175212A Use of aminopurine antiviral agents for the thratment and prophylaxis of latent herpesvirus infections |
| 03/04/1998 | CN1174742A Complex cow's milk gamma globulin and the making method thereof |
| 03/04/1998 | CN1174724A Application of patchouli oil used as germicide for skin |
| 03/04/1998 | CN1037608C Crystallizing acid addition salt of 3 -cephem -4 -carboxylic acid -1 -(2, 2 -dimethylpropionyloxy) ethyl ester non-emantiomorph prepn process |
| 03/03/1998 | US5723648 Intermediates for anti-microbial benzoheterocyclic compounds |
| 03/03/1998 | US5723631 Coumarin derivatives as retroviral inhibitors |
| 03/03/1998 | US5723627 Bactericides |
| 03/03/1998 | US5723609 Bis (hydroxymethyl) cyclobutyl purines |
| 03/03/1998 | US5723589 Nonglycoside linkage |
| 03/03/1998 | US5723495 Benzamidoxime prodrugs as antipneumocystic agents |
| 03/03/1998 | US5723490 THF-containing sulfonamide inhibitors of aspartyl protease |
| 03/03/1998 | US5723461 Quinoxalines, a process for their preparation and their use |
| 03/03/1998 | US5723449 Antisecretory agents and anticarcinogenic agents |
| 03/03/1998 | US5723447 Acetate formation in nonaqeous solvent |
| 03/03/1998 | US5723439 Pharmaceutical aerosol composition and application thereof for treatment and prophylaxis of viral diseases |
| 03/03/1998 | US5723316 α-1-antichymotrypsin analogues having chymase inhibiting activity |
| 03/03/1998 | US5723315 Secreted proteins and polynucleotides encoding them |
| 03/03/1998 | US5723144 Ointment for wound treatment |
| 03/03/1998 | US5723130 Adjuvants for vaccines against respiratory syncytial virus |
| 03/03/1998 | US5723125 Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
| 03/03/1998 | US5723121 Sugar modified interferon |
| 03/03/1998 | US5723120 Method of treating an IL-6 related disease with interleukin-6 receptor antagonists |
| 02/28/1998 | CA2212954A1 Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
| 02/26/1998 | WO1998007874A2 New systems for regulating genetic expression |
| 02/26/1998 | WO1998007866A1 Antigenic protein originating in infectious laryngotracheitis virus |
| 02/26/1998 | WO1998007864A1 Recombinant toxin fragments |
| 02/26/1998 | WO1998007859A2 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | WO1998007841A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 02/26/1998 | WO1998007833A1 Compositions and methods for use of defensin |
| 02/26/1998 | WO1998007745A2 Compositions and methods for treating infections using analogues of indolicidin |
| 02/26/1998 | WO1998007708A1 Isoxazoline derivatives useful as antimicrobials |
| 02/26/1998 | WO1998007706A1 New polycyclic phthalazin derivatives and their use |
| 02/26/1998 | WO1998007697A1 Arylsulfonylamino hydroxamic acid derivatives |
| 02/26/1998 | WO1998007437A1 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEPATITIS B COMPRISING EXTRACT OF PHYLLANTHUS USSURIENSIS AND/OR $i(PHYLLANTHUS URINARIA) |
| 02/26/1998 | WO1998007429A2 Antifungal composition with enhanced bioavailability |
| 02/26/1998 | WO1998007424A1 Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant streptococcus pneumonia |
| 02/26/1998 | WO1998003200A3 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease |
| 02/26/1998 | WO1998002546A3 Dna immunization against chlamydia infection |
| 02/26/1998 | WO1997049373A3 Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin |
| 02/26/1998 | WO1997039123A3 Secreted proteins |
| 02/26/1998 | DE19648962C1 DNA encoding peptide(s) from papilloma virus major capsid protein |
| 02/26/1998 | DE19633698A1 Neue Systeme zur Regulation der Genexpression New systems for the regulation of gene expression |
| 02/26/1998 | CA2264284A1 Arylsulfonylamino hydroxamic acid derivatives |
| 02/26/1998 | CA2264203A1 Compositions and methods for use of defensin |
| 02/26/1998 | CA2264192A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | CA2264074A1 Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant streptococcus pneumonia |
| 02/26/1998 | CA2263799A1 Compositions and methods for treating infections using analogues of indolicidin |
| 02/26/1998 | CA2262817A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 02/26/1998 | CA2261756A1 New polycyclic phthalazine derivatives and the use thereof |
| 02/25/1998 | EP0825194A2 An amide derivative of amythiamicin |
| 02/25/1998 | EP0825186A1 2-Aminobenzazepine derivatives and their use for the treatment of immunosuppression |
| 02/25/1998 | EP0824910A2 Use of a Krill Enzyme for the Treatment of Dental Plaque |
| 02/25/1998 | EP0824594A1 Improved methods for transfecting t cells |
| 02/25/1998 | EP0824548A1 Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits |
| 02/25/1998 | EP0824547A1 Anti-fungal peptides |
| 02/25/1998 | EP0824546A2 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/25/1998 | EP0824544A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use |
| 02/25/1998 | EP0824543A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use |
| 02/25/1998 | EP0824539A1 Dialkyltiacumicin compounds |
| 02/25/1998 | EP0824538A1 Saccharopeptides and derivatives thereof |
| 02/25/1998 | EP0824535A1 Antibacterial cephalosporins |
| 02/25/1998 | EP0824529A1 Benzothiazoles and benzoxazoles, as well as drugs containing them, their use and methods of preparing them |
| 02/25/1998 | EP0824524A1 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase |
| 02/25/1998 | EP0824523A1 Nitric oxide synthase inhibitors derived from cyclic amidines |
| 02/25/1998 | EP0824359A1 Peptide-based vaccine against papillomavirus infection |
| 02/25/1998 | EP0824358A1 Acellular pertussis vaccines and methods of preparation thereof |
| 02/25/1998 | EP0824357A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent |
| 02/25/1998 | EP0824355A1 Mistletoe extract and method |
| 02/25/1998 | EP0824350A1 Antifungal composition |
| 02/25/1998 | EP0590070B1 Broad spectrum antimicrobial compounds and methods of use |
| 02/25/1998 | CN1174559A Major outer membrane protein CD of Moraxella |
| 02/25/1998 | CN1174554A Rapamycin 42-oximes and hydroxylamines |
| 02/25/1998 | CN1174040A Compound antibacterial and antiviral veterinary medicine capable of raising immunity |
| 02/24/1998 | US5721359 Cephalosporin antibiotics |
| 02/24/1998 | US5721354 For treatment of infections, medical diagnosis |
| 02/24/1998 | US5721351 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/24/1998 | US5721349 Genetically altered mutant strain |
| 02/24/1998 | US5721346 Compounds of the secomacrolide and secoazalide class and a process for the preparation thereof |